{"created_at":"Mon Feb 09 15:31:20 +0000 2015","id":564808776717332480,"id_str":"564808776717332480","text":"An Interview With Cellceutix CEO Leo Ehrlich http:\/\/t.co\/hJJGIIA0c8 $MRK $CTIX","source":"\u003ca href=\"http:\/\/seekingalpha.com\" rel=\"nofollow\"\u003eSeeking Alpha\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2999752275,"id_str":"2999752275","name":"Long & Short Ideas","screen_name":"SA_LongShort","location":"","url":"http:\/\/seekingalpha.com\/analysis\/investing-ideas\/all","description":"Long and short ideas from Seeking Alpha. For all SA Twitter feeds, see https:\/\/twitter.com\/SeekingAlpha\/following","protected":false,"verified":false,"followers_count":76,"friends_count":31,"listed_count":3,"favourites_count":0,"statuses_count":547,"created_at":"Mon Jan 26 15:18:38 +0000 2015","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"360000","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/559733721251577858\/DhqkN2yb_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/559733721251577858\/DhqkN2yb_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/hJJGIIA0c8","expanded_url":"http:\/\/seekingalpha.com\/article\/2898526-an-interview-with-cellceutix-ceo-leo-ehrlich?source=twitter_sa_longshort","display_url":"seekingalpha.com\/article\/289852\u2026","indices":[45,67]}],"user_mentions":[],"symbols":[{"text":"MRK","indices":[68,72]},{"text":"CTIX","indices":[73,78]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1423495880666"}
{"created_at":"Mon Feb 09 17:40:05 +0000 2015","id":564841177716097024,"id_str":"564841177716097024","text":"The FDA's \"breakthrough therapy\" designation will no longer apply to hep C regimens. What that means for $BMY &amp; $MRK: http:\/\/t.co\/EHaiI8Xe1O","source":"\u003ca href=\"http:\/\/www.hootsuite.com\" rel=\"nofollow\"\u003eHootsuite\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":166597717,"id_str":"166597717","name":"The Fly","screen_name":"theflynews","location":"","url":"http:\/\/www.thefly.com","description":"First In Stock News","protected":false,"verified":false,"followers_count":8188,"friends_count":113,"listed_count":328,"favourites_count":8,"statuses_count":48122,"created_at":"Wed Jul 14 15:10:34 +0000 2010","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"254B82","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"254B82","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/538395653684998144\/25cnbJ3y_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/538395653684998144\/25cnbJ3y_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/EHaiI8Xe1O","expanded_url":"http:\/\/bit.ly\/1ESB4QR","display_url":"bit.ly\/1ESB4QR","indices":[122,144]}],"user_mentions":[],"symbols":[{"text":"BMY","indices":[105,109]},{"text":"MRK","indices":[116,120]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1423503605666"}
